Efficacy of Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery

NCT01066351 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Acute Renal Failure

Interventions

DRUG: beta erythropoietin
DRUG: placebo

Sponsor

Thammasat University